CTOs on the Move

Verana Health

www.veranahealth.com

 
Verana Health is a healthcare technology and analytics company entrusted by key medical associations to manage multi-specialty, real-world data at every stage of the analytics process—from entry to evidence. Anchored in ophthalmology, neurology, and urology, the Company acts as a linchpin in the healthcare data ecosystem, normalizing data and enhancing its clinical richness and quality to empower physicians and accelerate research for patients. By curating and applying advanced analytics to real-world clinical data, Verana Health helps life sciences partners enhance evidence generation, reinvent observational and prospective research, and drive innovations in specific disease areas.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Kirk Fjeldheim
 Chief Information Security Officer Profile
Jung Kim
 Director, Security and Compliance Profile

Funding

Verana Health raised $30M on 07/31/2018
Verana Health raised $100M on 02/05/2020
Verana Health raised $150M on 01/14/2022

Similar Companies

Ohio County EMS

Ohio County EMS is a Hartford, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eastern Connecticut Health Network

Eastern Connecticut Health Network, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Eastern Connecticut Health Network, Inc. is based in Manchester, CT. You can find more information on Eastern Connecticut Health Network, Inc. at www.echn.org

Addiction Counseling Services

Addiction Counseling Services is a North Miami Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hilltop Village-a Retirement

Hilltop Village-a Retirement is a Euclid, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Knight Therapeutics Inc

Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. Knight Therapeutics' shares are expected to begin trading on the TSX-V on March 3, 2014 under the symbol GUD.